Hematology & Oncology Doctors in Dover, DE Accepting Medicare
3 Hematology & Oncology doctors found. Showing 1 - 3
 Kathrina L Chua, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 640 S Governors Ave, Dover, DE 19904 Phone: 302-744-7994 Fax: 302-744-7993 |
 Dr. Lamberto Magno Arellano, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 811 Monroe Ter, Dover, DE 19904 Phone: 302-734-3537 Fax: 302-734-0538 |
Rishi Sawhney, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 640 S State St Fl 2, Dover, DE 19901 Phone: 302-744-7994 Fax: 302-744-7993 |
News Archive
Scientists identify new class of immune cells that suppress genital herpes
Fred Hutchinson Cancer Research Center and University of Washington scientists have identified a class of immune cells that reside long-term in the genital skin and mucosa and are believed to be responsible for suppressing recurring outbreaks of genital herpes.
NSF grants funds to develop next-generation nano-CT imaging system
In 1991, Ge Wang produced the first paper on spiral cone-beam computed tomography (CT), now an imaging technique used in the mainstream of the medical CT field. Today, Wang, known as a pioneer in this field, and his colleagues have been awarded more than $1.3 million from the National Science Foundation (NSF) to develop the next-generation nano-CT imaging system, which promises to greatly reduce the required dose of radiation.
Claros point-of-care system for PSA receives European CE Mark approval
Claros Diagnostics, a developer of novel point-of-care in vitro diagnostic systems, today announced the CE Mark approval for its rapid quantitative point-of-care diagnostic platform, which can now be used for prostate specific antigen (PSA) testing throughout the European Union. The approved system consists of a small portable analyzer and credit card-sized disposable.
Investigational device to treat brain cancer shows promise in early studies
New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields - called Tumor-Treating Fields (TTFields) - more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor.
› Verified 4 days ago
Internal Medicine
Family Medicine
Emergency Medicine
Radiology
Psychiatry & Neurology
Pediatrics
Surgery
Cardiovascular Disease
Obstetrics & Gynecology
Anesthesiology
Orthopaedic Surgery